Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients

Intensive Care Medicine

Volumn 35, Issue 5, 2009, Pages 903-908

  Senn, Laurence ^a   Eggimann, Philippe ^a   Ksontini, Riadh ^a   Pascual, Andres ^a   Demartines, Nicolas ^a   Bille, Jacques ^a   Calandra, Thierry ^a   Marchetti, Oscar ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Candidiasis; Caspofungin; Fungal infection; Pancreatitis; Prevention; Surgery

Indexed keywords

CASPOFUNGIN;

ABDOMINAL INFECTION; ACUTE HEMORRHAGIC PANCREATITIS; ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; CHOLESTASIS; CLINICAL ARTICLE; CYTOLYSIS; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGAL COLONIZATION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; LIVER TOXICITY; LOADING DRUG DOSE; MALE; NONHUMAN; PROSPECTIVE STUDY; RASH; SIDE EFFECT; SURGICAL PATIENT; SURVIVAL RATE; TREATMENT OUTCOME;

ABDOMINAL ABSCESS; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG ADMINISTRATION SCHEDULE; ECHINOCANDINS; FEMALE; HUMANS; INTESTINAL PERFORATION; LAPAROTOMY; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 67349215507     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1405-8     Document Type: Article

References (30)

1. O Marchetti J Bille U Fluckiger P Eggimann C Ruef J Garbino T Calandra MP Glauser MG Tauber D Pittet 2004 Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000 Clin Infect Dis 38 311 320 (Pubitemid 38200105)
2. ME Bougnoux G Kac P Aegerter C d'Enfert JY Fagon 2008 Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome Intensive Care Med 34 292 299
3. P Eggimann P Francioli J Bille R Schneider MM Wu G Chapuis R Chiolero A Pannatier J Schilling S Geroulanos MP Glauser T Calandra 1999 Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients Crit Care Med 27 1066 1072 (Pubitemid 29314312)
4. JJ De Waele D Vogelaers S Blot F Colardyn 2003 Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy Clin Infect Dis 37 208 213 (Pubitemid 36930351)
5. T Calandra J Bille R Schneider F Mosimann P Francioli 1989 Clinical significance of Candida isolated from peritoneum in surgical patients Lancet 2 1437 1440 (Pubitemid 20012067)
6. P Sandven H Qvist E Skovlund KE Giercksky 2002 Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations Crit Care Med 30 541 547 (Pubitemid 34214614)
7. T Calandra O Marchetti 2004 Clinical trials of antifungal prophylaxis among patients undergoing surgery Clin Infect Dis 39 Suppl 4 S185 S192 (Pubitemid 40169345)
8. D Pittet M Monod PM Suter E Frenk R Auckenthaler 1994 Candida colonization and subsequent infections in critically ill surgical patients Ann Surg 220 751 758 (Pubitemid 24376373)
9. JH Rex JD Sobel 2001 Prophylactic antifungal therapy in the intensive care unit Clin Infect Dis 32 1191 1200 (Pubitemid 32427691)
10. T Calandra O Marchetti 2002 Antifungal prophylaxis for intensive care unit patients: let's fine tune it Intensive Care Med 28 1698 1700 (Pubitemid 35435469)
11. R Piarroux F Grenouillet P Balvay V Tran G Blasco L Millon A Boillot 2004 Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients Crit Care Med 32 2443 2449 (Pubitemid 39648226)
12. AF Shorr K Chung WL Jackson PE Waterman MH Kollef 2005 Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis Crit Care Med 33 1928 1935 (Pubitemid 41306511)
13. M Prella J Bille M Pugnale B Duvoisin M Cavassini T Calandra O Marchetti 2005 Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies Diagn Microbiol Infect Dis 51 95 101 (Pubitemid 40215418)
14. L Ostrosky-Zeichner C Sable J Sobel BD Alexander G Donowitz V Kan CA Kauffman D Kett RA Larsen V Morrison M Nucci PG Pappas ME Bradley S Major L Zimmer D Wallace WE Dismukes JH Rex 2007 Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting Eur J Clin Microbiol Infect Dis 26 271 276 (Pubitemid 46572022)
15. C Leon S Ruiz-Santana P Saavedra B Almirante J Nolla-Salas F Varez-Lerma J Garnacho-Montero MA Leon 2006 A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization Crit Care Med 34 730 737 (Pubitemid 43308263)
16. RK Pelz CW Hendrix SM Swoboda M Diener-West WG Merz J Hammond PA Lipsett 2001 Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients Ann Surg 233 542 548 (Pubitemid 32234953)
17. J Garbino DP Lew JA Romand S Hugonnet R Auckenthaler D Pittet 2002 Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination Intensive Care Med 28 1708 1717 (Pubitemid 35435471)
18. KM Ho J Lipman GJ Dobb SA Webb 2005 The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis Crit Care 9 R710 R717
19. EG Playford AC Webster TC Sorrell JC Craig 2006 Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials J Antimicrob Chemother 57 628 638
20. Cruciani M, de Lalla F, Mengoli C (2005) Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 31:1479-1487
21. MG Schuster JE Edwards Jr JD Sobel RO Darouiche AW Karchmer S Hadley G Slotman H Panzer P Biswas JH Rex 2008 Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial Ann Intern Med 149 83 90
22. PG Pappas JH Rex JD Sobel SG Filler WE Dismukes TJ Walsh JE Edwards 2004 Guidelines for treatment of candidiasis Clin Infect Dis 38 161 189 (Pubitemid 38113025)
23. JR Wingard WG Merz MG Rinaldi TR Johnson JE Karp R Saral 1991 Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole N Engl J Med 325 1274 1277
24. D Abi-Said E Anaissie O Uzun I Raad H Pinzcowski S Vartivarian 1997 The epidemiology of hematogenous candidiasis caused by different Candida species Clin Infect Dis 24 1122 1128 (Pubitemid 127774267)
25. P Eggimann J Garbino D Pittet 2003 Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect Dis 3 685 702 (Pubitemid 37345347)
26. AF Shorr DR Lazarus JH Sherner WL Jackson M Morrel VJ Fraser MH Kollef 2007 Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia Crit Care Med 35 1077 1083 (Pubitemid 46598958)
27. J Mora-Duarte R Betts C Rotstein AL Colombo L Thompson-Moya J Smietana R Lupinacci C Sable N Kartsonis J Perfect 2002 Comparison of caspofungin and amphotericin B for invasive candidiasis N Engl J Med 347 2020 2029 (Pubitemid 35461658)
28. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. Clinical and laboratory Standards Institute, Wayne, PA
29. Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Published 9 August 2006. http://ctep.cancer.gov/forms/CTCAEv3.pdf , 2008
30. PE Charles F Dalle H Aube JM Doise JP Quenot LS Aho P Chavanet B Blettery 2005 Candida spp. colonization significance in critically ill medical patients: a prospective study Intensive Care Med 31 393 400